4411 | VOIS 003 X 0031 | kaiser | 03/27/2015 10:34:43 AM |
1737 | NXHZ .0199 Company acquisition of Uranium mining | kaiser | 07/22/2013 10:30:31 PM |
1736 | Blast this link on Twitter, FB, Skype rooms, | sevenOdouble | 07/22/2013 3:55:45 PM |
1735 | $SEEK is looking good | Princess_Jess | 07/22/2013 2:11:17 PM |
1734 | NXHZ .02 | kaiser | 07/22/2013 2:06:33 PM |
1733 | NXHZ .018 | kaiser | 07/22/2013 12:20:53 PM |
1732 | AFTC 003 X 0031 | kaiser | 07/22/2013 10:14:42 AM |
1731 | AFTC 003 | kaiser | 07/22/2013 10:10:04 AM |
1730 | NXHZ .017 | kaiser | 07/22/2013 10:06:28 AM |
1729 | SAPX 004 | kaiser | 07/22/2013 10:01:51 AM |
1728 | AFTC 0029 | kaiser | 07/22/2013 10:01:09 AM |
1727 | SAPX 0038 X 004 | kaiser | 07/22/2013 9:49:18 AM |
1726 | AFTC 0028 nice alternative fuel company | kaiser | 07/22/2013 9:48:20 AM |
1725 | SAPX 0035 X 004 | kaiser | 07/22/2013 9:37:50 AM |
1724 | SAPX 0034 looks like reversal starting. Should be | kaiser | 07/21/2013 10:49:19 PM |
1723 | NXHZ .0169 Company acquisition of Uranium mining | kaiser | 07/21/2013 10:47:50 PM |
1722 | RARS 0021 | kaiser | 07/18/2013 12:21:58 PM |
1721 | SAPX 0027 news out. | kaiser | 07/18/2013 9:18:25 AM |
1720 | CFGX 004 nice news out | kaiser | 07/18/2013 8:57:26 AM |
1719 | DLCR 0086 nice move today. Closed up 28%. Should | kaiser | 07/17/2013 10:55:09 PM |
1718 | SAPX 0027 oversold down here. Should be getting | kaiser | 07/17/2013 10:52:50 PM |
1717 | RARS 002 buyers coming back into this stock. | kaiser | 07/17/2013 10:49:26 PM |
1716 | CFGX 004 X 0044 | kaiser | 07/17/2013 2:40:25 PM |
1715 | DLCR 0088 | kaiser | 07/17/2013 2:27:27 PM |
1714 | DLCR 0085 | kaiser | 07/17/2013 2:16:44 PM |
1713 | DLCR 008 | kaiser | 07/17/2013 2:12:39 PM |
1712 | SAPX 0031 should be ready for a nice move | kaiser | 07/17/2013 12:36:51 PM |
1711 | DLCR 006 like this stock here. | kaiser | 07/17/2013 12:27:12 PM |
1710 | SAPX 0035 nice volume coming in. Looks ready | kaiser | 07/17/2013 9:50:56 AM |
1709 | CFGX 0042 hitting | kaiser | 07/17/2013 9:35:14 AM |
1708 | SAFC 0064 | kaiser | 07/16/2013 3:51:11 PM |
1707 | SAFC 0064's up | kaiser | 07/16/2013 3:44:22 PM |
1706 | SAFC 0054 | kaiser | 07/16/2013 3:34:41 PM |
1705 | SAFC 005 X 0052 | kaiser | 07/16/2013 3:34:08 PM |
1704 | SAFC 0048 | kaiser | 07/16/2013 3:17:39 PM |
1703 | SAFC 0046 | kaiser | 07/16/2013 3:01:54 PM |
1702 | SAFC 004 X 0045 | kaiser | 07/16/2013 1:35:22 PM |
1701 | CFGX 0042 filings out last week. Company uplist | kaiser | 07/16/2013 10:18:21 AM |
1700 | SAFC 0031 X 0033 | kaiser | 07/16/2013 10:10:59 AM |
1699 | SAFC 0024 chart setting up here. Looks like a | kaiser | 07/15/2013 10:58:35 PM |
1698 | Check out SEEk | Princess_Jess | 07/15/2013 7:26:28 PM |
1697 | NLST < News Out | Golden Cross ! *Read | stockstock | 07/15/2013 1:37:52 PM |
1696 | DSCR 0011 nice buys coming in. Looks ready for | kaiser | 07/15/2013 12:09:53 PM |
1695 | BONU 0081. Penny break should be coming | kaiser | 07/15/2013 12:01:31 PM |
1694 | BONU 0076 | kaiser | 07/15/2013 11:58:59 AM |
1693 | BONU 0072 X 0073 | kaiser | 07/15/2013 11:58:19 AM |
1692 | BONU 007 | kaiser | 07/15/2013 11:53:02 AM |
1691 | BONU 0067 | kaiser | 07/15/2013 11:18:19 AM |
1690 | BONU 006 X 0064 | kaiser | 07/15/2013 10:58:30 AM |
1689 | BONU 006's going | kaiser | 07/15/2013 10:51:53 AM |
1688 | HYII 0099 | kaiser | 07/15/2013 10:46:53 AM |
Recent Articles
- Autoliv's Strategic Move: Retiring Shares for Growth
- Autoliv Takes Significant Steps by Retiring Shares Efficiently
- VARON Oxygen Solutions: Empowering Freedom Through Innovation
- Docusign Expands Leadership with Stéphane Barberet in EMEA
- Skanska's Major Investment in Sustainable Housing Development
- Understanding the Monthly Factsheet for Tetragon Financial
- Hansa Biopharma Offers Promising Insights on Imlifidase in Transplants
- Positive Five-Year Data on Imlifidase in Kidney Transplants
- Amaroq Minerals Closes Major Fundraising Effort
- Elis Enhances Shareholder Value Through Strategic Buybacks
- IMCD Expands Horizons with Acquisition of Apus Química
- KuCoin Thailand Partners with Finansia Syrus to Enhance Assets
- Understanding Aktsiaselts Infortar's Dividends and Operations
- AB Science Updates Loan Restructuring for Strategic Growth
- Haffner Energy Achieves Key Milestones in 2024-2025 Financial Year
- Skanska Commits CZK 1.6 Billion to Innovative Housing Project
- SWI Group Strengthens European Strategy with New Data Centre
- Tetragon Financial Group's Monthly Overview and Insights
- SWI Group's Innovative Data Centre Expansion in Europe
- MIMARU Introduces Enhanced Rooms to Enchant Pokemon Fans
- Klotho Neurosciences Advances Gene Therapy for ALS Patients
- KuCoin Thailand Partners with Finansia Syrus to Innovate Digital Assets
- Aker Solutions and Cognizant Team Up for IT Modernization
- IMCD Enhances Advanced Materials Solutions with Apus Química
- Infortar Announces Upcoming Dividend Payments for Shareholders
- Trifork Group's Commitment to Shareholder Value Through Buyback
- Revolutionary IoT Chip by CT Group Poised to Dominate Market
- Nextensa and Promobe Team Up for Eosys Development
- Sermatec and Foxconn Drive Innovation in Energy Storage Solutions
- The Bouzy Group Unveils New Coastal Lifestyle Investment Option
- Vallourec Enhances Collaboration with ADNOC Through Major Order
- Nextensa Advancing Footprint with Eosys Construction Project
- Endeavour Mining's Recent Share Buy-Back Program Highlights
- Celebrating 20 Years of Reddit: A Distinctive Social Media Journey
- Nicox Achieves Major Milestone in NCX 470 Clinical Trial
- Vallourec's Major Supply Order from ADNOC Signals Growth
- Sanofi Announces Release of Q2 2025 Aide Mémoire for Investors
- Fosun International's Accolades Highlight Corporate Excellence
- Exciting Progress: Nicox's NCX 470 Trial Nears Major Milestone
- Sanofi Unveils Release of Q2 2025 Financial Insights
- Totalkredit A/S Unveils Latest Prepayment Insights and Data
- Prepayment Trends and Insights from Nykredit Realkredit A/S
- Exciting Launch: White Castle's New Crispy Chicken Slider
- Idorsia's Innovative Vaccine Platform: A New Era in Medicine
- Addex Therapeutics Invests CHF 2 Million in Stalicla for CNS Innovation
- ARGX-119 Clinical Advancement: A New Era for CMS Treatment
- Roche Announces Leadership Changes in Executive Committee
- Riliprubart Receives Orphan Drug Designation in Japan for CIDP
- SEALSQ Corp Enhances Quantum Resilience through Investment in WECAN
- Riliprubart's Orphan Drug Designation: A Path to Innovation